
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality
Rima Hajjo, Alexander Tropsha
Pharmaceutical Research (2020) Vol. 37, Iss. 11
Open Access | Times Cited: 17
Rima Hajjo, Alexander Tropsha
Pharmaceutical Research (2020) Vol. 37, Iss. 11
Open Access | Times Cited: 17
Showing 17 citing articles:
Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1186-1186
Open Access | Times Cited: 83
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1186-1186
Open Access | Times Cited: 83
Trained Immunity: An Overview and the Impact on COVID-19
Justin M. Brueggeman, Juan Zhao, Madison Schank, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Justin M. Brueggeman, Juan Zhao, Madison Schank, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Understanding COVID-19 in children: immune determinants and post-infection conditions
Gioacchino Andrea Rotulo, Paolo Palma
Pediatric Research (2023) Vol. 94, Iss. 2, pp. 434-442
Open Access | Times Cited: 34
Gioacchino Andrea Rotulo, Paolo Palma
Pediatric Research (2023) Vol. 94, Iss. 2, pp. 434-442
Open Access | Times Cited: 34
Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design
Daisuke Onozuka, Yuta Tanoue, Shuhei Nomura, et al.
International Journal of Epidemiology (2021) Vol. 51, Iss. 1, pp. 75-84
Open Access | Times Cited: 41
Daisuke Onozuka, Yuta Tanoue, Shuhei Nomura, et al.
International Journal of Epidemiology (2021) Vol. 51, Iss. 1, pp. 75-84
Open Access | Times Cited: 41
Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Mai Helmy Hassan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Mai Helmy Hassan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes
Rima Hajjo, Ensaf Momani, Dima A. Sabbah, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Rima Hajjo, Ensaf Momani, Dima A. Sabbah, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects
Rima Hajjo, Dima A. Sabbah, Alexander Tropsha
Pathogens (2022) Vol. 11, Iss. 7, pp. 743-743
Open Access | Times Cited: 17
Rima Hajjo, Dima A. Sabbah, Alexander Tropsha
Pathogens (2022) Vol. 11, Iss. 7, pp. 743-743
Open Access | Times Cited: 17
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, et al.
Current Topics in Medicinal Chemistry (2021) Vol. 21, Iss. 7, pp. 571-596
Closed Access | Times Cited: 18
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, et al.
Current Topics in Medicinal Chemistry (2021) Vol. 21, Iss. 7, pp. 571-596
Closed Access | Times Cited: 18
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel
ACS Omega (2020) Vol. 5, Iss. 46, pp. 29765-29779
Open Access | Times Cited: 16
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel
ACS Omega (2020) Vol. 5, Iss. 46, pp. 29765-29779
Open Access | Times Cited: 16
Reductionist methodology and the ambiguity of the categories of race and ethnicity in biomedical research: an exploratory study of recent evidence
Joanna K. Malinowska, Tomasz Żuradzki
Medicine Health Care and Philosophy (2022) Vol. 26, Iss. 1, pp. 55-68
Open Access | Times Cited: 11
Joanna K. Malinowska, Tomasz Żuradzki
Medicine Health Care and Philosophy (2022) Vol. 26, Iss. 1, pp. 55-68
Open Access | Times Cited: 11
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
Gwenolé Loas, Pascal Le Corre
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 691-691
Open Access | Times Cited: 13
Gwenolé Loas, Pascal Le Corre
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 691-691
Open Access | Times Cited: 13
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
Mohamed El‐Tanani, Khaled Abdul‐Aziz Ahmed, Ashok K. Shakya, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 799-799
Open Access | Times Cited: 5
Mohamed El‐Tanani, Khaled Abdul‐Aziz Ahmed, Ashok K. Shakya, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 799-799
Open Access | Times Cited: 5
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer
Sanaa K. Bardaweel, R. S. Alomari, Rima Hajjo
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2882-2899
Closed Access | Times Cited: 1
Sanaa K. Bardaweel, R. S. Alomari, Rima Hajjo
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2882-2899
Closed Access | Times Cited: 1
Unveiling the Intricacies of Monoamine Oxidase-A (MAO-A) Inhibition in Colorectal Cancer: Computational Systems Biology, Expression Patterns, and the Anticancer Therapeutic Potential
Sanaa K. Bardaweel, Husam ALSalamat, Rima Hajjo, et al.
ACS Omega (2024) Vol. 9, Iss. 33, pp. 35703-35717
Open Access | Times Cited: 1
Sanaa K. Bardaweel, Husam ALSalamat, Rima Hajjo, et al.
ACS Omega (2024) Vol. 9, Iss. 33, pp. 35703-35717
Open Access | Times Cited: 1
Epidemiology Analysis of COVID‐19 Data and Associated Effects of Pandemic Containment Procedures, Viral Variants, and Vaccines: Lessons Learned From Middle Eastern Jordan’s Experience
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Advances in Public Health (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Advances in Public Health (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Can Anti-Parasitic Drugs Help Control COVID-19?
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, et al.
Future Virology (2022) Vol. 17, Iss. 5, pp. 315-339
Open Access | Times Cited: 7
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, et al.
Future Virology (2022) Vol. 17, Iss. 5, pp. 315-339
Open Access | Times Cited: 7
Health economic analyses of secondary vaccine effects: a systematic review and policy insights
Kimberly M. Thompson, Kamran Badizadegan
Expert Review of Vaccines (2021) Vol. 21, Iss. 3, pp. 297-312
Open Access | Times Cited: 4
Kimberly M. Thompson, Kamran Badizadegan
Expert Review of Vaccines (2021) Vol. 21, Iss. 3, pp. 297-312
Open Access | Times Cited: 4